Oncology Institute Inc (TOI)
The Oncology Institute, Inc. is a healthcare company focused on oncology services in the United States. Through its three operating segments—Specialty Pharmacy, Patient Services, and Clinical Trials & Other—it provides physician services, in-house infusion, specialty pharmacy dispensing, clinical trial management, radiation therapy, and outpatient blood product transfusion services. The company also supports patients with educational seminars, counseling, support groups, and around-the-clock assistance. In addition, it operates community clinics and infusion suites and offers palliative care programs. Its specialty pharmacy provides both in-office and mail-order access to oral and self-injectable medications used alongside cancer treatment. The Oncology Institute serves adult and senior cancer patients and was founded in 2007. It is headquartered in Cerritos, California, and its common stock is listed on Nasdaq under the ticker TOI.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-TOI
|
$5.88
|
9.1% Upside
|
Fair
|
$8.40
|
55.8% Upside
|
Bargain
|
Good
|
—
|
—
|
—
|
0.0%
|
August 11, 2026
|
-14.9x
|
-33.3x
|
1.0x
|
549.9 M
|
617.5 M
|
16.0%
|
87.3%
|
2.4
|
—
|
70.8%
|
